AI
Isomorphic Labs Enters Human Trials With AI-Designed Drugs, Testing Industry’s $3 Billion Bet
DeepMind spinoff's 2026 clinical trials mark first major test of whether machine learning can genuinely reduce drug failure rates beyond early-stage screening.
7 min read
·